244 related articles for article (PubMed ID: 35723349)
1. Molecular Structure-Based Screening of the Constituents of
Adinortey CA; Kwarko GB; Koranteng R; Boison D; Obuaba I; Wilson MD; Kwofie SK
Curr Issues Mol Biol; 2022 Feb; 44(2):963-987. PubMed ID: 35723349
[TBL] [Abstract][Full Text] [Related]
2.
Kazeem MI; Mayaki AM; Ogungbe BF; Ojekale AB
Iran J Pharm Res; 2016; 15(Suppl):37-44. PubMed ID: 28228802
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Evaluation of the Anti-Diabetic Potential of Aqueous Acetone
Akinyede KA; Oyewusi HA; Hughes GD; Ekpo OE; Oguntibeju OO
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011387
[TBL] [Abstract][Full Text] [Related]
4. Protein tyrosine phosphatase 1B and α-glucosidase inhibitory activities of Pueraria lobata root and its constituents.
Seong SH; Roy A; Jung HA; Jung HJ; Choi JS
J Ethnopharmacol; 2016 Dec; 194():706-716. PubMed ID: 27769948
[TBL] [Abstract][Full Text] [Related]
5. Drug Repurposing of FDA Compounds against α-Glucosidase for the Treatment of Type 2 Diabetes: Insights from Molecular Docking and Molecular Dynamics Simulations.
Rashid RSM; Temurlu S; Abourajab A; Karsili P; Dinleyici M; Al-Khateeb B; Icil H
Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111312
[TBL] [Abstract][Full Text] [Related]
6. Screening and identification of α-glucosidase inhibitors from Cyclocarya paliurus leaves by ultrafiltration coupled with liquid chromatography-mass spectrometry and molecular docking.
Li YJ; Wan GZ; Xu FC; Guo ZH; Chen J
J Chromatogr A; 2022 Jul; 1675():463160. PubMed ID: 35635870
[TBL] [Abstract][Full Text] [Related]
7. Crude extract and isolated bioactive compounds from Notholirion thomsonianum (Royale) Stapf as multitargets antidiabetic agents: in-vitro and molecular docking approaches.
Mahnashi MH; Alqahtani YS; Alqarni AO; Alyami BA; Jan MS; Ayaz M; Ullah F; Rashid U; Sadiq A
BMC Complement Med Ther; 2021 Oct; 21(1):270. PubMed ID: 34706708
[TBL] [Abstract][Full Text] [Related]
8. Recent Updates on Phytoconstituent Alpha-Glucosidase Inhibitors: An Approach towards the Treatment of Type Two Diabetes.
Kashtoh H; Baek KH
Plants (Basel); 2022 Oct; 11(20):. PubMed ID: 36297746
[TBL] [Abstract][Full Text] [Related]
9. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Novel Coumarin Analogs against the α-Glucosidase Protein Target of Diabetes Mellitus: Pharmacophore-Based QSAR, Docking, and Molecular Dynamics Simulation Studies.
Maurya AK; Mulpuru V; Mishra N
ACS Omega; 2020 Dec; 5(50):32234-32249. PubMed ID: 33376861
[TBL] [Abstract][Full Text] [Related]
11. Natural Triterpenoids Isolated from Akebia trifoliata Stem Explants Exert a Hypoglycemic Effect via α-Glucosidase Inhibition and Glucose Uptake Stimulation in Insulin-Resistant HepG2 Cells.
Bian G; Yang J; Elango J; Wu W; Bao B; Bao C
Chem Biodivers; 2021 May; 18(5):e2001030. PubMed ID: 33779055
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory evaluation of
Zabidi NA; Ishak NA; Hamid M; Ashari SE; Mohammad Latif MA
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):109-121. PubMed ID: 33249946
[TBL] [Abstract][Full Text] [Related]
13. The management of diabetes mellitus-imperative role of natural products against dipeptidyl peptidase-4, α-glucosidase and sodium-dependent glucose co-transporter 2 (SGLT2).
Abbas G; Al Harrasi A; Hussain H; Hamaed A; Supuran CT
Bioorg Chem; 2019 May; 86():305-315. PubMed ID: 30738330
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of different fractions of Calotropis procera (Asclepiadaceae) in streptozotocin induced experimental model of diabetic neuropathy.
Yadav SK; Nagori BP; Desai PK
J Ethnopharmacol; 2014 Mar; 152(2):349-57. PubMed ID: 24486599
[TBL] [Abstract][Full Text] [Related]
15. Rational in silico design of novel α-glucosidase inhibitory peptides and in vitro evaluation of promising candidates.
Ibrahim MA; Bester MJ; Neitz AW; Gaspar ARM
Biomed Pharmacother; 2018 Nov; 107():234-242. PubMed ID: 30096627
[TBL] [Abstract][Full Text] [Related]
16. α-glucosidase inhibitors from plants: A natural approach to treat diabetes.
Kumar S; Narwal S; Kumar V; Prakash O
Pharmacogn Rev; 2011 Jan; 5(9):19-29. PubMed ID: 22096315
[TBL] [Abstract][Full Text] [Related]
17.
Awan ZA; Khan HA; Jamal A; Shams S; Zheng G; Wadood A; Shahab M; Khan MI; Kalantan AA
J Biomol Struct Dyn; 2024 Jan; ():1-11. PubMed ID: 38294714
[TBL] [Abstract][Full Text] [Related]
18. Alpha-Glucosidase and Alpha-Amylase Inhibitory Activities, Molecular Docking, and Antioxidant Capacities of
Etsassala NGER; Badmus JA; Marnewick JL; Egieyeh S; Iwuoha EI; Nchu F; Hussein AA
Antioxidants (Basel); 2022 Feb; 11(2):. PubMed ID: 35204260
[TBL] [Abstract][Full Text] [Related]
19. Identification of highly potent α-glucosidase inhibitory and antioxidant constituents from Zizyphus rugosa bark: enzyme kinetic and molecular docking studies with active metabolites.
Sichaem J; Aree T; Lugsanangarm K; Tip-Pyang S
Pharm Biol; 2017 Dec; 55(1):1436-1441. PubMed ID: 28320255
[TBL] [Abstract][Full Text] [Related]
20. Phytochemical analysis and antidiabetic potential of Elaeagnus umbellata (Thunb.) in streptozotocin-induced diabetic rats: pharmacological and computational approach.
Nazir N; Zahoor M; Nisar M; Khan I; Karim N; Abdel-Halim H; Ali A
BMC Complement Altern Med; 2018 Dec; 18(1):332. PubMed ID: 30545352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
